Aprea Therapeutics, Inc.

( )
APRE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
ABBVAbbVie, Inc. 0.85%93.831.9%$1197.07m
BMYBristol-Myers Squibb Co. 0.71%61.321.0%$1025.25m
JNJJohnson & Johnson 0.37%147.270.7%$985.01m
PFEPfizer Inc. -0.22%35.930.9%$950.41m
MRKMerck & Co., Inc. 0.82%82.220.7%$866.82m
LLYEli Lilly & Co. -1.02%149.171.1%$513.08m
AZNAstraZeneca Plc -0.04%53.851.2%$284.98m
NVSNovartis AG 0.93%85.910.2%$149.95m
GSKGlaxoSmithKline Plc 0.11%41.700.2%$128.57m
NVONovo Nordisk A/S 0.23%64.490.1%$86.32m
SNYSanofi 0.30%50.100.2%$78.21m
RGENRepligen Corp. -1.28%120.267.1%$68.18m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.08%68.140.0%$53.16m
TPTXTurning Point Therapeutics, Inc. 1.28%62.980.0%$37.37m
RETAReata Pharmaceuticals, Inc. -2.49%126.303.4%$35.33m

Company Profile

Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA.